Then, we checked for additional target genes and focused on cMYC and the aryl hydrocarbon receptor (AHR). The former is a proto-oncogene with different effects on tumor cells and the latter plays a central role in tolerogenic immunity to promote GBM tumorigenesis [34, 35]. This evidence concerns the gene AHR and neoplasm.